Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Transgene discloses phase IIb data for TG-4010

May 30, 2014

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

May 30, 2014

BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer

May 29, 2014

Ganymed reports results from phase IIa gastroesophageal cancer trial

May 28, 2014

FDA grants orphan drug designation to Advaxis' ADXS-cHER2 for osteosarcoma

May 28, 2014

FDA grants orphan drug status to SAR-650984 for cancer

May 28, 2014

Cel-Sci expands phase III study of Multikine to new U.S. site

May 28, 2014

BioInvent sells back ADC-1013 rights to Alligator Bioscience

May 28, 2014

European researchers disclose new anti-S100-A4 MAbs

May 27, 2014

Daiichi Sankyo receives additional indication approval in Japan for Ranmark

May 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026